Genetic Technologies Limited (GNTLF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -12.21 Million AUD | -23.14% |
| 2023 | -9.91 Million AUD | -131.06% |
| 2022 | -4.29 Million AUD | 39.25% |
| 2021 | -7.06 Million AUD | -16.1% |
| 2020 | -6.08 Million AUD | -1.43% |
| 2019 | -5.99 Million AUD | 4.27% |
| 2018 | -6.26 Million AUD | 21.63% |
| 2017 | -7.99 Million AUD | 5.48% |
| 2016 | -8.45 Million AUD | -4.44% |
| 2015 | -8.09 Million AUD | 13.23% |
| 2014 | -9.33 Million AUD | -2.47% |
| 2013 | -9.1 Million AUD | -54.2% |
| 2012 | -5.9 Million AUD | -711.78% |
| 2011 | 965.55 Thousand AUD | -71.04% |
| 2010 | 3.33 Million AUD | 142.63% |
| 2009 | -7.81 Million AUD | -301.87% |
| 2008 | -1.94 Million AUD | -25.09% |
| 2007 | -1.55 Million AUD | 74.78% |
| 2006 | -6.16 Million AUD | 20.58% |
| 2005 | -7.76 Million AUD | -1.45% |
| 2004 | -7.65 Million AUD | -77.0% |
| 2003 | -4.32 Million AUD | 51.28% |
| 2002 | -8.87 Million AUD | -158.76% |
| 2001 | -3.43 Million AUD | -22.31% |
| 2000 | -2.8 Million AUD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 FY | -12.58 Million AUD | -26.88% |
| 2024 Q2 | -5.16 Million AUD | -100.0% |
| 2024 Q1 | -2.58 Million AUD | 43.66% |
| 2024 Q4 | -7.05 Million AUD | 0.0% |
| 2023 Q1 | -2.69 Million AUD | 37.51% |
| 2023 Q3 | -2.51 Million AUD | 53.4% |
| 2023 Q2 | -5.39 Million AUD | -100.0% |
| 2023 FY | -9.91 Million AUD | -131.06% |
| 2023 Q4 | -4.58 Million AUD | -82.4% |
| 2022 Q3 | -1.82 Million AUD | 63.28% |
| 2022 Q1 | -1.94 Million AUD | 53.47% |
| 2022 FY | -4.29 Million AUD | 39.25% |
| 2022 Q2 | -4.97 Million AUD | -155.51% |
| 2022 Q4 | -4.31 Million AUD | -136.28% |
| 2021 Q4 | -4.18 Million AUD | -124.05% |
| 2021 Q1 | -1.84 Million AUD | 54.68% |
| 2021 Q2 | -4.44 Million AUD | -141.08% |
| 2021 Q3 | -1.86 Million AUD | 58.0% |
| 2021 FY | -7.06 Million AUD | -16.1% |
| 2020 Q1 | -1.32 Million AUD | 61.1% |
| 2020 Q2 | -3.08 Million AUD | -133.91% |
| 2020 Q3 | -2.36 Million AUD | 23.3% |
| 2020 Q4 | -4.06 Million AUD | -71.78% |
| 2020 FY | -6.08 Million AUD | -1.43% |
| 2019 Q4 | -3.39 Million AUD | -73.83% |
| 2019 Q1 | -1.55 Million AUD | -2.91% |
| 2019 Q2 | -1.55 Million AUD | 0.0% |
| 2019 FY | -5.99 Million AUD | 4.27% |
| 2019 Q3 | -1.95 Million AUD | -25.44% |
| 2018 Q3 | -1.51 Million AUD | 10.46% |
| 2018 Q1 | -1.68 Million AUD | 13.6% |
| 2018 FY | -6.26 Million AUD | 21.63% |
| 2018 Q2 | -1.68 Million AUD | 0.0% |
| 2018 Q4 | -1.51 Million AUD | 0.0% |
| 2017 Q2 | -2.04 Million AUD | 0.0% |
| 2017 FY | -7.99 Million AUD | 5.48% |
| 2017 Q4 | -1.95 Million AUD | 0.0% |
| 2017 Q3 | -1.95 Million AUD | 4.28% |
| 2017 Q1 | -2.04 Million AUD | 7.99% |
| 2016 Q3 | -2.21 Million AUD | -9.5% |
| 2016 Q4 | -2.21 Million AUD | 0.0% |
| 2016 Q2 | -2.02 Million AUD | 0.0% |
| 2016 Q1 | -2.02 Million AUD | 3.42% |
| 2016 FY | -8.45 Million AUD | -4.44% |
| 2015 FY | -8.09 Million AUD | 13.23% |
| 2015 Q4 | -2.09 Million AUD | 0.0% |
| 2015 Q3 | -2.09 Million AUD | 25.93% |
| 2015 Q2 | -2.83 Million AUD | 0.0% |
| 2015 Q1 | -2.83 Million AUD | -15.75% |
| 2014 Q4 | -2.44 Million AUD | 0.0% |
| 2014 FY | -9.33 Million AUD | -2.47% |
| 2014 Q1 | -2.65 Million AUD | 3.7% |
| 2014 Q2 | -2.65 Million AUD | 0.0% |
| 2014 Q3 | -2.44 Million AUD | 7.86% |
| 2013 FY | -9.1 Million AUD | -54.2% |
| 2013 Q4 | -2.75 Million AUD | 0.0% |
| 2013 Q3 | -2.75 Million AUD | 0.0% |
| 2012 Q2 | - AUD | 0.0% |
| 2012 FY | -5.9 Million AUD | -711.78% |
| 2012 Q3 | - AUD | 0.0% |
| 2012 Q4 | - AUD | 0.0% |
| 2011 Q4 | - AUD | 0.0% |
| 2011 FY | 965.55 Thousand AUD | -71.04% |
| 2011 Q2 | - AUD | 0.0% |
| 2010 Q4 | - AUD | 0.0% |
| 2010 FY | 3.33 Million AUD | 142.63% |
| 2009 Q4 | - AUD | 0.0% |
| 2009 FY | -7.81 Million AUD | -301.87% |
| 2008 FY | -1.94 Million AUD | -25.09% |
| 2008 Q2 | -66.52 Thousand AUD | -101.51% |
| 2008 Q1 | 4.42 Million AUD | 149.16% |
| 2008 Q4 | -14.35 Million AUD | -316.43% |
| 2008 Q3 | 6.63 Million AUD | 10067.03% |
| 2007 Q1 | 2.7 Million AUD | 119.52% |
| 2007 FY | -1.55 Million AUD | 74.78% |
| 2007 Q2 | -2.49 Million AUD | -191.99% |
| 2007 Q3 | 4.24 Million AUD | 270.19% |
| 2007 Q4 | -8.99 Million AUD | -312.04% |
| 2006 FY | -6.16 Million AUD | 20.58% |
| 2006 Q1 | 3.37 Million AUD | 118.48% |
| 2006 Q2 | -1.41 Million AUD | -141.84% |
| 2006 Q3 | 2.56 Million AUD | 281.87% |
| 2006 Q4 | -13.87 Million AUD | -640.11% |
| 2005 Q2 | -186.77 Thousand AUD | -104.96% |
| 2005 FY | -7.76 Million AUD | -1.45% |
| 2005 Q1 | 3.76 Million AUD | 0.0% |
| 2005 Q3 | 3.55 Million AUD | 2001.27% |
| 2005 Q4 | -18.26 Million AUD | -614.47% |
| 2004 FY | -7.65 Million AUD | -77.0% |
| 2003 FY | -4.32 Million AUD | 51.28% |
| 2002 FY | -8.87 Million AUD | -158.76% |
| 2001 FY | -3.43 Million AUD | -22.31% |
| 2000 FY | -2.8 Million AUD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Bio Medica Corporation | -1.24 Million USD | -883.109% |
| Arrayit Corporation | -3.62 Million USD | -237.064% |
| Atlantic International Corp. | -5.73 Million USD | -112.999% |
| Biocept, Inc. | -31.98 Million USD | 61.823% |
| Bioqual, Inc. | -19.63 Thousand USD | -62076.454% |
| CardioGenics Holdings Inc | -772.14 Thousand USD | -1481.343% |
| DermTech, Inc. | -103.73 Million USD | 88.23% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.48 Billion USD | 100.491% |
| HTG Molecular Diagnostics, Inc. | -20.82 Million USD | 41.38% |
| iMD Companies, Inc. | -175.44 Thousand USD | -6859.527% |
| IDenta Corp. | -1499.00 USD | -814457.171% |
| Interpace Biosciences, Inc. | 2.8 Million USD | 535.457% |
| Integrative Health Technologies, Inc. | 38.69 Thousand USD | 31659.09% |
| InVitro International | -25.33 Thousand USD | -48087.426% |
| Lumos Diagnostics Holdings Limited | -7.12 Million USD | -71.444% |
| Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | -20911.516% |
| Medical Imaging Corp. | -819.48 Thousand USD | -1389.995% |
| NovelStem International Corp. | -3.52 Million USD | -246.31% |
| Optigenex Inc. | 1.39 Million USD | 977.905% |
| PharmChem, Inc. | 973.14 Thousand USD | 1354.714% |
| Proteome Sciences plc | -1.62 Million USD | -653.252% |
| Response Genetics, Inc | -21.37 Million USD | 42.882% |
| Rennova Health, Inc. | -1.4 Million USD | -766.259% |
| RushNet, Inc. | -684.7 Thousand USD | -1683.281% |
| ScreenPro Security Inc. | -2.59 Million USD | -370.995% |
| Stella Diagnostics Inc. | -11.42 Million USD | -6.855% |
| StageZero Life Sciences Ltd. | -7.74 Million USD | -57.617% |
| Todos Medical Ltd. | -9.74 Million USD | -25.259% |